Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Privat

Showing results (181-190 of 187) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 187 results.
Neurotoxicology|January 1, 1997
GK 11: promising additional neuroprotective therapy for organophosphate poisoningG Lallement, J C Mestries, A Privat, et al.
European Journal of Pharmacology|August 14, 1992
Inhibition of locus coeruleus neurons by the phencyclidine analog, N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine: evidence for potent indirect adrenoceptor agonist propertiesK Chergui, H Akaoka, J L Brunet, et al.
Spinal Cord|December 21, 2006
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial designD Lammertse, M H Tuszynski, J D Steeves, et al.
Spinal Cord|December 21, 2006
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethicsM H Tuszynski, J D Steeves, J W Fawcett, et al.
Journal of Neuroscience Research|March 13, 2008
Adult human spinal cord harbors neural precursor cells that generate neurons and glial cells in vitroC Dromard, H Guillon, V Rigau, et al.
Spinal Cord|December 21, 2006
Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measuresJ D Steeves, D Lammertse, A Curt, et al.
Spinal Cord|December 21, 2006
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trialsJ W Fawcett, A Curt, J D Steeves, et al.
Pageof 19

Showing results (181-190 of 187) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 187 results.
Neurotoxicology|January 1, 1997
GK 11: promising additional neuroprotective therapy for organophosphate poisoningG Lallement, J C Mestries, A Privat, et al.
European Journal of Pharmacology|August 14, 1992
Inhibition of locus coeruleus neurons by the phencyclidine analog, N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine: evidence for potent indirect adrenoceptor agonist propertiesK Chergui, H Akaoka, J L Brunet, et al.
Spinal Cord|December 21, 2006
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial designD Lammertse, M H Tuszynski, J D Steeves, et al.
Spinal Cord|December 21, 2006
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethicsM H Tuszynski, J D Steeves, J W Fawcett, et al.
Journal of Neuroscience Research|March 13, 2008
Adult human spinal cord harbors neural precursor cells that generate neurons and glial cells in vitroC Dromard, H Guillon, V Rigau, et al.
Spinal Cord|December 21, 2006
Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measuresJ D Steeves, D Lammertse, A Curt, et al.
Spinal Cord|December 21, 2006
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trialsJ W Fawcett, A Curt, J D Steeves, et al.
Pageof 19